Chinese Biotech Bets On Intravenous 3CL Antiviral Contender For COVID-19

 
• By Dexter Jie Yan
  
Frontier CEO on antiviral drugs
small Chinese biotech moving forward with IV antiviral for COVID-19 • Source: Alamy

More from China

More from Focus On Asia